Plerixafor for Stem Cell Mobilization in Allogeneic Stem Cell Donors

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2015.11.1082
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Hematopoietic Stem Cell Mobilization With Plerixafor in Sickle Cell Disease

Haematologica
Hematology
2018English

Hematopoietic Stem Cell Mobilization

Haematologica
Hematology
2008English

Allogeneic Hematopoietic Stem Cell Transplantation From Alternative Donors for Acquired Aplastic Anemia

Journal of Hematopoietic Cell Transplantation
2016English

Allogeneic Stem Cell Transplantation for Sickle Cell Disease

Current Opinion in Hematology
Hematology
2016English

Efficacy of Late Hematopoietic Stem Cell Mobilization 35-40 Hours After Administration of Plerixafor

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Single-Agent Plerixafor Mobilization to Collect Autologous Stem Cells for Use in Gene Therapy for Severe Sickle Cell Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Allogeneic Hematopoietic Stem Cell Transplantation

Archives of Internal Medicine
2002English

Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts From Healthy Stem Cell Donors Mobilized With Either G-CSF Alone or G-CSF and Plerixafor

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Allogeneic Stem Cell Transplantation for Acquired Pure Red Cell Aplasia

American Journal of Hematology
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy